Contrasting Organigram Global (NASDAQ:OGI) and Mobia Medical (NASDAQ:MOBI)

Organigram Global (NASDAQ:OGI) and Mobia Medical (NASDAQ:MOBI) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings and institutional ownership.

Institutional & Insider Ownership

34.6% of Organigram Global shares are held by institutional investors. 0.1% of Organigram Global shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Organigram Global and Mobia Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Organigram Global	28.14%	-14.52%	-9.81%
Mobia Medical	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings for Organigram Global and Mobia Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1	0	2	0	2.33
Mobia Medical	1	1	5	0	2.57

Mobia Medical has a consensus price target of $20.75, indicating a potential upside of 77.65%. Given Mobia Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Mobia Medical is more favorable than Organigram Global.

Earnings and Valuation

This table compares Organigram Global and Mobia Medical”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07 million	0.96	-$17.70 million	($0.13)	-9.69
Mobia Medical	$32.04 million	12.14	-$46.50 million	($19.30)	-0.61

Organigram Global has higher revenue and earnings than Mobia Medical. Organigram Global is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

Summary

Organigram Global beats Mobia Medical on 7 of the 13 factors compared between the two stocks.

About Organigram Global

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

About Mobia Medical

Mobia Medical Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc. is based in AUSTIN, Texas.